BCR and diffuse large B-cell lymphoma: Furthermore, newly identified molecular subsets of DLBCL recognize tumor types extending beyond the initial cell-of-origin subgroups with specific dependence on BCR deregulation that correlate to poor prognosis [10,11,12].